PAUL CAMPOS: Open Payments
NPI 1457664062 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 47 payments from 9 companies in 2025. Trend: 2023 $1,217 · 2024 $968 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 32 | $403 |
| ABBVIE INC. | 3 | $73 |
| PFIZER INC. | 3 | $67 |
| Merz Pharmaceuticals, LLC | 1 | $64 |
| Medtronic, Inc. | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
| Antares Pharma, Inc. | 2 | $36 |
| ABIOMED | 1 | $26 |
| Globus Medical, Inc. | 1 | $18 |
Products named: Belbuca, XTAMPZA, NURTEC ODT, Xeomin, BOTOX, JOURNAVX, XYOSTED, SYNCHROMEDII.
Industry payments across CA — which companies pay providers there.
